DDO-02267
DDO-02267 is a selective and lysine-targeting covalent inhibitor of ALKBH5, with an IC50 value of 0.49 μM. DDO-02267 increases N6-methyladenosine (m6A) levels and targets the ALKBH5-AXL signaling axis. DDO-02267 can serve as a probe for investigating the biological function of mRNA demethylase[1].
Product Specifications
CAS Number
2919768-58-2
UNSPSC
12352005
Target
Anaplastic lymphoma kinase (ALK) ; Fat Mass and Obesity-associated Protein (FTO)
Related Pathways
Metabolic Enzyme/Protease; Protein Tyrosine Kinase/RTK
Field of Research
Cancer
Smiles
O=CC1=C(O)C2=C(C=CC=C2)C(S(=O)(NC(C3=NC=CC(C(O)=O)=C3)=O)=O)=C1
Molecular Formula
C18H12N2O7S
Molecular Weight
400.36
References & Citations
[1]Fei WL, et al. Discovery of the salicylaldehyde-based compound DDO-02267 as a lysine-targeting covalent inhibitor of ALKBH5. Eur J Med Chem. 2024 Dec 23;284:117183.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR10349829 96 Well
Chicken AP 3 complex subunit sigma 1 (AP3S1) ELISA Kit
Sign In for Pricing
View Details 